Digital Therapy for MCI and Early Stage Dementia.
MindAhead is the first therapy app specifically developed for mild cognitive impairment (MCI) and mild dementia. With a scientifically-based behavioral activation program, it directly combats memory loss.
The Scientists behind MindAhead
Seth A. Gale, MD
Co-Director, Brain Health Program, Division of Cognitive and Behavioral Neurology at Brigham and Women’s Hospital
Assistant Professor of Neurology, Harvard Medical School
Robert Brady, PhD
Robert Brady is an expert in Behavioral Activation and teaches and researches at Dartmouth College.
Supported by clinical research
Clinical research by Rovner et al. has shown that behavioral activation therapy can significantly reduce the risk of progressive dementia.
“We found that after 2 years, participants in the behavioral activation group were only half as likely to show deterioration in cognitive tests at a given time point.” – Dr. Barry Rovner
Easy to use
The app is specifically designed for people with mild cognitive impairment and early dementia. Simple controls, large font size and visual support help users to navigate the app. Only basic smartphone skills are required.
At each stage of the development, people affected by MCI and mild dementia were involved to make sure the app meets their needs.
Slow down cognitive decline
You cannot cure dementia. But you can slow it down.
Behavioral activation therapy stimulates the brain in three important areas: social, physical, cognitive. This can slow down cognitive decline and help stay independent for longer.
“There is no other digital therapy that uses the behavioral activation approach for dementia. It is a unique approach designed to give back some degree of control over the rate of cognitive decline.” – Patrick Fissler, PhD
Join the waiting list
In order to use MindAhead Active, please register for a spot on the waiting list. We will do our best to give you or a loved one access to the program as soon as possible.
Supported by:
